V. Di Marco
About
In The Last Decade
V. Di Marco
267 papers receiving 8.2k citations
Peers
Comparison fields: 5 of 135
- Epidemiology 7.0k
- Hepatology 5.7k
- Endocrinology, Diabetes and Metabolism 1.0k
- Pathology and Forensic Medicine 773
- Surgery 770
Countries citing papers authored by V. Di Marco
This map shows the geographic impact of V. Di Marco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Di Marco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Di Marco more than expected).
Fields of papers citing papers by V. Di Marco
This network shows the impact of papers produced by V. Di Marco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Di Marco. The network helps show where V. Di Marco may publish in the future.
Co-authorship network of co-authors of V. Di Marco
This figure shows the co-authorship network connecting the top 25 collaborators of V. Di Marco. A scholar is included among the top collaborators of V. Di Marco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Di Marco. V. Di Marco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 26 | |
| 3 | 17 | |
| 4 | 44 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 32 | |
| 8 | The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases. | 6 |
| 9 | Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C | 2 |
| 10 | 83 | |
| 11 | 27 | |
| 12 | 5 | |
| 13 | The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. | 0 |
| 14 | Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV. | 5 |
| 15 | Epidemiology, parasitology and neuropathology of coenurosis in sheep and goats in Sicily. | 2 |
| 16 | Guidelines for the treatment of chronic viral hepatitis | 4 |
| 17 | 52 | |
| 18 | COMMUNITY-ACQUIRED CHRONIC HEPATITIS-C IN AN AREA OF HIGH SEROTYPE-1 ENDEMICITY - INTERFERON FOR 6 OR 12 MONTHS | 2 |
| 19 | 16 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.